• A Novel Pathogenic Variant in the SCA25-Related Gene Expanding the Etiology of Early-Onset and Progressive Cerebellar Ataxia in Childhood
• Age-related differences of cerebellar cortex and nuclei: MRI findings in healthy controls and its application to spinocerebellar ataxia (SCA6) patients
• Charge transport properties of ideal and natural DNA segments, as mutation detectors
• Clinical phenotyping and genetic diagnosis of a large cohort of Sudanese families with hereditary spinocerebellar degenerations
• Clinical, neuroimaging and genetic findings in children with hereditary ataxia: single center study
• Coexistence of spinocerebellar ataxia autosomal recessive type 21 and Ehlers-Danlos syndrome spondylodysplastic type 3 in a patient
• Demographics and Clinical Characteristics of Autosomal Dominant Spinocerebellar Ataxia in Canada
• Effect of speech therapy on quality of life in patients with spinocerebelar ataxia type 3
• Hepatic fibrosis: a manifestation of the liver disease evolution in patients with Ataxia-telangiectasia
• Heterozygous PNPT1 Variants Cause Spinocerebellar Ataxia Type 25
• High-Resolution Motion-corrected 7.0-T MRI to Derive Morphologic Measures from the Human Cerebellum in Vivo
• Liver Assessment in Patients with Ataxia-Telangiectasia: Transient Elastography Detects Early Stages of Steatosis and Fibrosis
• Spinocerebellar ataxia 13 and 25
• Spinocerebellar Ataxia 36 is a Frequent Cause of Hereditary Ataxia in Eastern Spain
• Spinocerebellar ataxia type 31: A clinical and radiological literature review
• Spinocerebellar ataxia with sensory neuropathy (SCA25)
• Synthesis and cloning of long repeat sequences using single-stranded circular DNA
• Targeted long-read sequencing captures CRISPR editing and AAV integration outcomes in brain
• Therapeutic effects of engineered exosome-based miR-25 and miR-181a treatment in spinocerebellar ataxia type 3 mice by silencing ATXN3